Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04949256 |
|---|---|
| Brief Title: | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) |
| First Submitted : | June 29, 2021 |
| First Submitted that Met QC Criteria : | June 29, 2021 |
| First Posted : | July 2, 2021 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 7, 2024 |